Recent Updates
Recently added Catalysts

Hemopatch, standard preventive measures

Phase 3

Prolonged Air Leak | Unknown | Other |Baxter International Inc.|Last Updated: Aug 9, 2021

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedCONTROLLED
Total Trials1
Total Enrollment260
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02491671Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung ResectionPHASE3 COMPLETED 260Nov 24, 2015Jun 30, 2019Aug 9, 20216 Spain
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Number of Participants With Prolonged Air Leak (PAL)
From day of surgery to the fifth postoperative day

Prevalence of Prolonged Air Leak (PAL) measured as binary variable (YES/NO) and recorded, from day of surgery to the fifth postoperative day, in the study questionnaire. The occurrence of the outcome will be recorded if air leak exists 5 days or more after surgery

Secondary Endpoints
Duration of Air Leaks
Check everyday from day of surgery up to 38 days post-operative at maximum
Number of Participants With at Least One Chest Tube Reinsertion
From day of surgery up to 30 days thereafter
Number of Participants With One or More Readmission
30 days post-operative
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposePREVENTION
Treatment Arms
ArmTypeDescription
Experimental groupEXPERIMENTALExperimental group: At the end of lung resection, lung sutures and 1.5 cm of lung parenchyma on each side will be covered by Hemopatch. No additional measures for preventing air leak will be indicated. In the case of massive air leak in spite of the use of Hemopatch, each surgeon will decide on the indication of additional sutures of tissue plasties. These cases will be accounted for failures on an intention to treat basis.
Control groupOTHERControl group: The standard preventive measures will be followed in each center, including reinforcement of sutures, pleural tents, suturing pericardial or subcutaneous fat
Interventions
NameTypeDescription
HemopatchDEVICE -
standard preventive measuresPROCEDURE -
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 80 Years
SexALL
Healthy VolunteersNo
Study Sites6

Inclusion Criteria: * Scheduled anatomical lung resection indicated for any non-infectious disease (excluding Pneumonectomy) * Patients classified in class D according estimated risk of PAL * Age between 18 and 80 years Exclusion Criteria: * Those patients that according to Investigator assessmen...

Countries:Spain
Unlock Eligibility Criteria